Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dayu Shi

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Leukemia & Lymphoma|November 5, 2020
Variables associated with self-reported anxiety and depression symptoms in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitor therapyDayu Shi, Zongru Li, Yongjie Li, et al.
Medicine|November 9, 2019
Phlegmonous gastritis in a patient with mixed-phenotype acute leukemia in the neutropenia phase during chemotherapy: A case reportDayu Shi, Jinde He, Meng Lv, et al.
The American Journal of Chinese Medicine|October 15, 2013
Wedelia chinensis inhibits nasopharyngeal carcinoma CNE-1 cell growth by inducing G2/M arrest in a Chk1-dependent pathwayManyu Liu, Weizhang Wang, Xiaobo Li, et al.
Optics Letters|November 4, 2025
200 G self-coherent PON based on SiP CROW filter-enabled dual-polarization carrier-extracted self-coherent detectionHaojie Zhu, Yuhao Fang, Weiqi Lu, et al.
Optics Express|August 13, 2025
Demonstration of 200G pre-amplified self-coherent PONYuhao Fang, Haojie Zhu, Weiqi Lu, et al.
Optics Letters|October 1, 2025
Neural network-based dynamic nonlinear MIMO equalization in 3-D polarization multiplexed direct detection systemsWeiqi Lu, Yuhao Fang, Yang Zou, et al.
Sensors (Basel, Switzerland)|March 6, 2021
On Improving 5G Internet of Radio Light Security Based on LED Fingerprint Identification MethodDayu Shi, Xun Zhang, Lina Shi, et al.
Annals of Hematology|June 13, 2026
Efficacy and safety of crovalimab versus eculizumab in complement inhibitor-naïve patients with paroxysmal nocturnal hemoglobinuria: Chinese subgroup analysis of the phase 3 COMMODORE 2 studyHongyan Tong, Zenghua Lin, Chen Yang, et al.
Frontiers in Psychiatry|June 25, 2021
Mental Health in Persons With Chronic Myeloid Leukemia During the SARS-CoV-2 Pandemic: The Need for Increased Access to Health Care ServicesMei Bao, Sen Yang, Robert Peter Gale, et al.
European Journal of Haematology|November 13, 2024
Safety of Crovalimab Versus Eculizumab in Patients With Paroxysmal Nocturnal Haemoglobinuria (PNH): Pooled Results From the Phase 3 COMMODORE StudiesAlexander Röth, Rong Fu, Guangsheng He, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Leukemia & Lymphoma|November 5, 2020
Variables associated with self-reported anxiety and depression symptoms in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitor therapyDayu Shi, Zongru Li, Yongjie Li, et al.
Medicine|November 9, 2019
Phlegmonous gastritis in a patient with mixed-phenotype acute leukemia in the neutropenia phase during chemotherapy: A case reportDayu Shi, Jinde He, Meng Lv, et al.
The American Journal of Chinese Medicine|October 15, 2013
Wedelia chinensis inhibits nasopharyngeal carcinoma CNE-1 cell growth by inducing G2/M arrest in a Chk1-dependent pathwayManyu Liu, Weizhang Wang, Xiaobo Li, et al.
Optics Letters|November 4, 2025
200 G self-coherent PON based on SiP CROW filter-enabled dual-polarization carrier-extracted self-coherent detectionHaojie Zhu, Yuhao Fang, Weiqi Lu, et al.
Optics Express|August 13, 2025
Demonstration of 200G pre-amplified self-coherent PONYuhao Fang, Haojie Zhu, Weiqi Lu, et al.
Optics Letters|October 1, 2025
Neural network-based dynamic nonlinear MIMO equalization in 3-D polarization multiplexed direct detection systemsWeiqi Lu, Yuhao Fang, Yang Zou, et al.
Sensors (Basel, Switzerland)|March 6, 2021
On Improving 5G Internet of Radio Light Security Based on LED Fingerprint Identification MethodDayu Shi, Xun Zhang, Lina Shi, et al.
Annals of Hematology|June 13, 2026
Efficacy and safety of crovalimab versus eculizumab in complement inhibitor-naïve patients with paroxysmal nocturnal hemoglobinuria: Chinese subgroup analysis of the phase 3 COMMODORE 2 studyHongyan Tong, Zenghua Lin, Chen Yang, et al.
Frontiers in Psychiatry|June 25, 2021
Mental Health in Persons With Chronic Myeloid Leukemia During the SARS-CoV-2 Pandemic: The Need for Increased Access to Health Care ServicesMei Bao, Sen Yang, Robert Peter Gale, et al.
European Journal of Haematology|November 13, 2024
Safety of Crovalimab Versus Eculizumab in Patients With Paroxysmal Nocturnal Haemoglobinuria (PNH): Pooled Results From the Phase 3 COMMODORE StudiesAlexander Röth, Rong Fu, Guangsheng He, et al.
Pageof 2